Form 8-K - Current report:
SEC Accession No. 0001193125-24-282407
Filing Date
2024-12-20
Accepted
2024-12-20 06:05:31
Documents
50
Period of Report
2024-12-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d891246d8k.htm   iXBRL 8-K 69432
2 EX-2.1 d891246dex21.htm EX-2.1 612160
3 EX-4.1 d891246dex41.htm EX-4.1 69350
4 EX-10.1 d891246dex101.htm EX-10.1 69069
5 EX-10.2 d891246dex102.htm EX-10.2 315315
6 EX-10.3 d891246dex103.htm EX-10.3 91181
7 EX-99.1 d891246dex991.htm EX-99.1 31617
8 EX-99.2 d891246dex992.htm EX-99.2 31781
12 GRAPHIC g891246ex99_2s10g1.jpg GRAPHIC 73277
13 GRAPHIC g891246ex99_2s11g1.jpg GRAPHIC 32090
14 GRAPHIC g891246ex99_2s12g1.jpg GRAPHIC 86154
15 GRAPHIC g891246ex99_2s13g1.jpg GRAPHIC 84544
16 GRAPHIC g891246ex99_2s14g1.jpg GRAPHIC 90397
17 GRAPHIC g891246ex99_2s15g1.jpg GRAPHIC 92276
18 GRAPHIC g891246ex99_2s16g1.jpg GRAPHIC 98112
19 GRAPHIC g891246ex99_2s17g1.jpg GRAPHIC 99383
20 GRAPHIC g891246ex99_2s18g1.jpg GRAPHIC 103119
21 GRAPHIC g891246ex99_2s19g1.jpg GRAPHIC 80147
22 GRAPHIC g891246ex99_2s1g1.jpg GRAPHIC 35061
23 GRAPHIC g891246ex99_2s20g1.jpg GRAPHIC 104835
24 GRAPHIC g891246ex99_2s21g1.jpg GRAPHIC 102773
25 GRAPHIC g891246ex99_2s22g1.jpg GRAPHIC 101180
26 GRAPHIC g891246ex99_2s23g1.jpg GRAPHIC 75152
27 GRAPHIC g891246ex99_2s24g1.jpg GRAPHIC 71005
28 GRAPHIC g891246ex99_2s25g1.jpg GRAPHIC 88096
29 GRAPHIC g891246ex99_2s26g1.jpg GRAPHIC 93850
30 GRAPHIC g891246ex99_2s27g1.jpg GRAPHIC 112908
31 GRAPHIC g891246ex99_2s28g1.jpg GRAPHIC 26889
32 GRAPHIC g891246ex99_2s2g1.jpg GRAPHIC 286603
33 GRAPHIC g891246ex99_2s3g1.jpg GRAPHIC 37538
34 GRAPHIC g891246ex99_2s4g1.jpg GRAPHIC 32573
35 GRAPHIC g891246ex99_2s5g1.jpg GRAPHIC 81739
36 GRAPHIC g891246ex99_2s6g1.jpg GRAPHIC 101520
37 GRAPHIC g891246ex99_2s7g1.jpg GRAPHIC 110782
38 GRAPHIC g891246ex99_2s8g1.jpg GRAPHIC 97529
39 GRAPHIC g891246ex99_2s9g1.jpg GRAPHIC 89374
40 GRAPHIC g891246g1220054527842.jpg GRAPHIC 2092
41 GRAPHIC g891246g1220054528143.jpg GRAPHIC 2200
  Complete submission text file 0001193125-24-282407.txt   5175263

Data Files

Seq Description Document Type Size
9 XBRL TAXONOMY EXTENSION SCHEMA aadi-20241219.xsd EX-101.SCH 2842
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20241219_lab.xml EX-101.LAB 17995
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20241219_pre.xml EX-101.PRE 11256
52 EXTRACTED XBRL INSTANCE DOCUMENT d891246d8k_htm.xml XML 3649
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

EIN.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 241564953
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)